GoodRx Appoints New Chief Legal Officer, CLO Departs
Ticker: GDRX · Form: 8-K · Filed: May 30, 2024 · CIK: 1809519
| Field | Detail |
|---|---|
| Company | Goodrx Holdings, Inc. (GDRX) |
| Form Type | 8-K |
| Filed Date | May 30, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, legal, appointment
Related Tickers: GDRX
TL;DR
GoodRx gets a new CLO, David Schottenstein out, Sarah Schweppe in. $400k salary for Schweppe.
AI Summary
GoodRx Holdings, Inc. announced on May 29, 2024, the departure of its Chief Legal Officer, David M. Schottenstein. The company also announced the appointment of Sarah A. Schweppe as the new Chief Legal Officer, effective May 29, 2024. Schweppe will receive an annual base salary of $400,000 and will be eligible for equity awards.
Why It Matters
The change in Chief Legal Officer could signal shifts in the company's legal strategy or risk management approach. Investors will monitor the new CLO's performance and impact on regulatory compliance.
Risk Assessment
Risk Level: medium — Changes in key executive positions, especially the Chief Legal Officer, can introduce uncertainty regarding future legal and regulatory strategies.
Key Numbers
- $400,000 — New CLO Salary (Annual base salary for Sarah A. Schweppe)
Key Players & Entities
- GoodRx Holdings, Inc. (company) — Company filing the report
- David M. Schottenstein (person) — Departing Chief Legal Officer
- Sarah A. Schweppe (person) — Appointed Chief Legal Officer
- $400,000 (dollar_amount) — Annual base salary for new CLO
FAQ
What is the effective date of Sarah A. Schweppe's appointment as Chief Legal Officer?
Sarah A. Schweppe's appointment is effective May 29, 2024.
What was David M. Schottenstein's role at GoodRx Holdings, Inc.?
David M. Schottenstein was the Chief Legal Officer of GoodRx Holdings, Inc.
What is the annual base salary for the new Chief Legal Officer?
The annual base salary for Sarah A. Schweppe is $400,000.
What other compensation is Sarah A. Schweppe eligible for?
Sarah A. Schweppe will be eligible for equity awards.
What is the filing date of this 8-K report?
This 8-K report was filed on May 30, 2024.
Filing Stats: 1,229 words · 5 min read · ~4 pages · Grade level 10.8 · Accepted 2024-05-30 16:25:32
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share GDRX The Nasda
Filing Documents
- gdrx-20240529.htm (8-K) — 84KB
- ex991boardpressrelease_may.htm (EX-99.1) — 31KB
- 0001809519-24-000094.txt ( ) — 247KB
- gdrx-20240529.xsd (EX-101.SCH) — 2KB
- gdrx-20240529_lab.xml (EX-101.LAB) — 21KB
- gdrx-20240529_pre.xml (EX-101.PRE) — 12KB
- gdrx-20240529_htm.xml (XML) — 3KB
02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed in the Current Report on the Form 8-K filed by GoodRx Holdings, Inc. (the "Company") with the Securities and Exchange Commission (the "SEC") on March 14, 2024, Adam Karol notified the Company on March 12, 2024 of his decision to resign as a member of the Board of Directors of the Company (the "Board"), effective as of March 22, 2024. On May 29, 2024, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, elected Simon Patterson as a Class II director, effective immediately, to fill the vacancy on the Board created by the resignation of Adam Karol. As a Class II Director, Mr. Patterson's term will expire at the Company's 2025 Annual Meeting of Stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal. The Board also appointed Mr. Patterson as a member of the Board's Nominating and Corporate Governance Committee. The Board has determined that Mr. Patterson qualifies as "independent" under the rules of The Nasdaq Stock Market LLC. Mr. Patterson will not receive compensation for his service on the Board. Mr. Patterson, age 51, is a Managing Director at Silver Lake, a global technology investment firm ("Silver Lake"), which he joined in 2005. Prior to joining Silver Lake, Mr. Patterson was a member of the founding management team of Global Freight Exchange Limited, a logistics software company acquired by Descartes Systems Group, and worked in various management roles at the Financial Times, a leading news organization. Mr. Patterson serves on the board of directors of several private companies and is a Trustee and Vice Chairman of The Royal Foundation of The Prince and Princess of Wales and a member of Mark Carney's Panel of Senior Advisors at Chatham House. Previously, Mr. Patterson s
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. A copy of the Company's press release announcing the election of Mr. Patterson as a director and his committee assignment is attached hereto as Exhibit 99.1. The information in this Item 7.01 and Exhibit 99.1 attached hereto is furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and such information shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . The following exhibits are included with this Current Report on Form 8-K: 99.1* Press Release, dated May 30, 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. * Furnished herewith. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GOODRX HOLDINGS, INC. Date: May 30, 2024 By: /s/ Karsten Voermann Name: Karsten Voermann Title: Chief Financial Officer